In order to confirm that the SLE CD8+ T cell response was indeed characteristic of an inflammatory cytotoxic T cell, that modulating ROS was indeed capable of regulating the inflammatory/anti-inflammatory response, and that the above results were not artifacts, we treated ex vivo differentiated human Tc1 cells to oxidant/antioxidant reagents. This evidence concerns the gene CD8A and systemic lupus erythematosus.